In Section A, contributors will obtain unique doses and schedules of oral ABBV-744 pill to recognize Risk-free dosing program. Added contributors might be enrolled in the determined monotherapy dosign program. In Phase B, participants will get oral ruxolitinib and ABBV-744 will be provided as "insert-on" therapy. In Phase C, contributors https://alfredp888doy0.levitra-wiki.com/user